Search
Nafamostat
go.drugbank.com/drugs/DB12598InvestigationalThe use of nafamostat in Asian countries is approved as an anticoagulant therapy for patients undergoing continuous renal replacement therapy due to acute kidney injury. … It has been used in trials studying the prevention of Liver Transplantation and Postreperfusion Syndrome.
Categories: Analgesics, Non-NarcoticAlanosine
go.drugbank.com/drugs/DB05540InvestigationalAn amino acid analogue and antibiotic derived from the bacterium Streptomyces alanosinicus with antimetabolite and potential antineoplastic activities.
Categories: Compounds used in a research, industrial, or household settingAlnus incana subsp. rugosa pollen
go.drugbank.com/drugs/DB10453ApprovedAlnus incana subsp. rugosa pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractXanthium strumarium var. canadense pollen
go.drugbank.com/drugs/DB10462ApprovedXanthium strumarium var. canadense pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractPopulus deltoides subsp. monilifera pollen
go.drugbank.com/drugs/DB10465ApprovedPopulus deltoides subsp. monilifera pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractPopulus balsamifera subsp. trichocarpa pollen
go.drugbank.com/drugs/DB10754ApprovedPopulus balsamifera subsp. trichocarpa pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractAVI-5126
go.drugbank.com/drugs/DB05726InvestigationalAVI-526 is an improved formulation of [AVI-4557], developed for use on Vein Grafts before use in Heart by-Pass Graft Surgery. … The drug was under investigation in clinical trial NCT00451256 (Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)).
Crinecerfont
go.drugbank.com/drugs/DB18518ApprovedInvestigational[A264818] Crinecerfont was approved by the FDA in December 2024 as an adjunct to glucocorticoid replacement in patients with CAH.[L51973,L51993] … [A264818] The majority of the poor health outcomes in patients with CAH result from the inability to precisely titrate glucocorticoid dosages to both adequately replace the deficiency and sufficiently
Piclidenoson
go.drugbank.com/drugs/DB05511InvestigationalCF 101 (known generically as IB-MECA) is an anti-inflammatory drug for rheumatoid arthritis patients. Its novel mechanism of action relies on antagonism of adenoside A3 receptors. … CF101 is supplied as an oral drug and has an excellent safety profile.
Anisindione
go.drugbank.com/drugs/DB01125ApprovedAnisindione is a synthetic anticoagulant and an indanedione derivative. … II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver.